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Background: In vivo studies have demonstrated the ability of multi-walled carbon nanotubes (MWCNT) to induce
airway remodeling, a key feature of chronic respiratory diseases like asthma and chronic obstructive pulmonary
disease. However, the mechanism leading to remodeling is poorly understood. Particularly, there is limited insight
about the role of airway epithelial injury in these changes.
Objectives: We investigated the mechanism of MWCNT-induced primary human bronchial epithelial (HBE) cell
injury and its contribution in inducing a profibrotic response.
Methods: Primary HBE cells were exposed to thoroughly characterized MWCNTs (1.5-24 μg/mL equivalent to
0.37-6.0 μg/cm2) and MRC-5 human lung fibroblasts were exposed to 1:4 diluted conditioned medium from these
cells. Flow cytometry, ELISA, immunostainings/immunoblots and PCR analyses were employed to study cellular
mechanisms.
Results: MWCNT induced NLRP3 inflammasome dependent pyroptosis in HBE cells in a time- and dose-dependent
manner. Cell death and cytokine production were significantly reduced by antioxidants, siRNA to NLRP3, a caspase-1
inhibitor (z-WEHD-FMK) or a cathepsin B inhibitor (CA-074Me). Conditioned medium from MWCNT-treated HBE cells
induced significant increase in mRNA expression of pro-fibrotic markers (TIMP-1, Tenascin-C, Procollagen 1, and
Osteopontin) in human lung fibroblasts, without a concomitant change in expression of TGF-beta. Induction of
pro-fibrotic markers was significantly reduced when IL-1β, IL-18 and IL-8 neutralizing antibodies were added to the
conditioned medium or when conditioned medium from NLRP3 siRNA transfected HBE cells was used.
Conclusions: Taken together these results demonstrate induction of a NLRP3 inflammasome dependent but TGF-beta
independent pro-fibrotic response after MWCNT exposure.
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Multi-walled carbon nanotubes (MWCNT) exhibit unique
electrical, mechanical, thermal and optic properties, which
make them the material of choice for a variety of indus-
trial and consumer product applications. Apart from their
conventional utilizations in electronics, composite mate-
rials and optics, more recent applications of MWCNT in-
clude biomedical engineering, biosensors, drug delivery
and gene therapy [1-5]. Given their tremendous potential,
it is expected that their applications will continue to grow
over the coming years [6]. However, some of the proper-
ties which make MWCNTs a material of choice from an
engineering aspect (e.g. high tensile strength, high aspect
ratio and biopersistence) can also lead to potential toxicity
in biological systems [7-12].
At present there is no definitive proof of any human dis-
ease due to occupational or environmental exposure to
MWCNTs. However, a large body of literature show po-
tential toxic effects in rodents including acute lung in-
flammation, granuloma formation, epithelial-mesenchymal
transition and fibrosis [8,13-17]. Moreover, studies have
shown that MWCNTs can translocate from the lungs to
the pleura where they cause injury to the mesothelial lining
and therefore may cause pleural disease [16,18-21]. An ex-
cellent review about the pulmonary toxicity of MWCNT
can be found elsewhere [22]. These findings raise concerns
about the safety of MWCNTs and warrant further in-
depth mechanistic analyses to ensure the safety of workers
and consumers. Indeed, recent estimates indicate that
more than 6 million workers will be involved with nano-
technology by 2020, one third of whom will reside in the
US [23].
Airway remodeling, including increased deposition of
extracellular matrix proteins (ECM) plays significant role in
the development of symptoms associated with lung func-
tion decline in asthma and COPD [24,25]. In lungs more
than 10% of the total ECM is deposited/degraded each day
and fibrosis is actually a disturbed balance in favour of its
accumulation either due to excessive production or im-
paired degradation mechanisms [26]. MWCNT induce
airway remodeling and fibrosis in rodent models after re-
spiratory exposures [13,15,16]. However, the mechanisms
of such effects remain poorly elucidated. Some in vitro
studies have postulated the role of Transforming Growth
Factor-beta (TGF-β) production in the induction of pro-
fibrotic response after MWCNT exposures [8,13]. Still
others, using cell lines, postulated the role of epithelial-
mesenchymal transformation (EMT) in airway fibrosis
[17,27]. These studies mainly focussed on the role of lung
macrophages as key mediators in airway fibrosis in rodent
models and did not address the injury to airway epithelia as
a contributor to these responses. Using a relevant transla-
tional model, we explore the mechanistic pathway of pri-
mary human epithelial injury and its contribution in airwayremodeling after MWCNT exposures. We report here that
MWCNT induce pyroptosis (caspase-1-dependent inflam-
matory cell death) in primary human bronchial epithelial
cells. Furthermore, we demonstrate a novel pro-fibrotic
mechanism after MWCNT exposures of primary human
bronchial epithelial (HBE) cells, which involves nucleotide-
binding oligomerization domain (NOD)-like receptor pro-
tein 3 (NLRP3) inflammasome activation in HBE cells,
inducing Tenascin-C (TN-C), Osteopontin (OPN), Tissue
Inhibitor of Metalloprotease-1 (TIMP-1) and Procollagen-1
(PC-1) expression, and proliferation in fibroblasts. More-
over, we demonstrate that this process occurs without de-
novo TGF-β expression and can be effectively modulated
by siRNA inhibition of epithelial NLRP3 activation.
Results
Characterization of nanomaterials and their suspensions
Detailed physico-chemical characterization of MWCNTs
was performed before cell culture testing. Data provided by
the manufacturer were verified by an independent source
and have been reported previously [18]. Briefly, the ICP-
AES measurements by the independent source showed
99% elemental carbon, 0.34% Ni and 0.03% La and 0.7% O2
(Figure 1). These nanotubes have 10–30 nm average exter-
nal diameters, 0.5-40 μm average length and 109.29 m2/g
BET surface area. High resolution TEM and SEM images of
MWCNT dry powder is given in Figure 1. MWCNT were
suspended in cell culture medium (24 μg/mL) and sus-
pensions were analyzed for hydrodynamic diameter and
zeta potentials using DLS technique. DLS revealed that
MWCNT form aggregates of 129 ± 45 nm size (Additional
file 1). Carbon Black (CB) NPs and Min-u-Sil showed 95 ±
10 nm and 363 ± 64 nm hydrodynamic diameters respec-
tively. Zeta potential analyses revealed −13 ± 2 mV, −12 ±
3 mV and −8 ± 5 mV values for MWCNT, CB and Min-U-
Sil respectively. MWCNT and CB samples were tested free
of bacterial endotoxin contamination (<0.3 EU/mL) by end-
point chromogenic limulus amebocyte assay (LAL assay).
MWCNTs enter HBE cells and cause ultra-structural
damage
MWCNTs were taken up by primary HBE cells and were
found either in vesicles or free inside the cytoplasm
(Additional file 2). In most instances MWCNT clumps/
bundles were seen inside vesicles (Additional file 2B and
C), however, in some cases we found single nanotubes in
contact with the cell membrane or in vesicular mem-
branes, which appeared to be piercing through the mem-
brane (Additional file 2D).
MWCNT induce NLRP3 inflammasome dependent
pyroptosis
MWCNT exposure at 12 and 24 μg/mL induced sig-
nificant cell death after 24 hours of exposure (flow
Figure 1 Physico-chemical characteristics of MWCNT powder and suspensions. A) summary of characteristics in a table format. pDi refer to
polydispersity index B, C) TEM and D) SEM analyses of MWCNT powder.
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after CB NP exposure (shape control/negative control)
while Min-U-Sil (particulate positive control) did cause
significant toxicity. Hydrogen peroxide (H2O2) was used
as positive control for oxidative stress. A kinetic analysis
(4, 18, 24 and 48 hours exposure) revealed significant cell
death induction starting at 18 hours with 24 μg/mL
MWCNT exposure and at 24 hours with 12 μg/ml
MWCNT exposure with the response being persistent up
to 48 hours (Additional file 3). Cell death estimation was
verified using three independent methods i.e. flow cy-
tometry (propidium iodide staining), LDH assay and
trypan blue exclusion cell counts). All three assays for
cytotoxicity estimation demonstrated comparable results
(Additional file 4A-B). Furthermore, MWCNT exposure
caused a significant increase in caspase-1 positive cells
(Figure 2B). These results were also confirmed using
western blot analysis for total and cleaved caspase 1
(Additional file 5). A significant increase in cathepsin B re-
lease from HBE cells was also confirmed by immunohisto-
chemistry (Additional file 6). Treatment of HBE cells with
caspase-1 inhibitor (z-WEHD-FMK) and lysosomal prote-
ase cathepsin B inhibitor (CA- 074Me) either alone or in
combination significantly protected the cells from
MWCNT-induced toxicity (Figure 2C). Further, we dem-
onstrated that siRNA against NLRP3 significantly reduced
cell death (Figure 2D) of HBE cells confirming its role in
the cytotoxic responses induced by MWCNTs.Mechanism of MWCNT-induced inflammatory response
A significant increase in the release of inflammatory
mediators (IL-1β, IL-18 and IL-8) in cell culture super-
natants was observed after 24 hours of MWCNT ex-
posure (Figure 3A-C). An increase in the levels of IL-1β
and IL-8 were observed even at non-cytotoxic dose
(with 2 out of three tested methods) suggesting an in-
flammatory response in living cells, as opposed to
cytokine release from ruptured cells. However, no sig-
nificant change in the levels of GRO-α, IP-10, IL-6, and
IL-12 was observed, while IFN-γ, MIP-1α, RANTES and
TNF-α were only detected in control LPS treated cells
(data not shown). A time course (16, 24 and 48 hours)
of inflammatory mediator production after MWCNT
exposure is presented in Additional file 7. MWCNT-
induced increase in IL-1β production was significantly
reduced after pre-treatment with glycine (an inhibitor of
pore formation), or caspase-1 and cathepsin B inhibitors
(Figure 3D). Further, we demonstrated that siRNA
against NLRP3 significantly reduced IL-1β production
(Figure 3E) by HBE cells confirming the role of NLRP3
inflammasome in the cytotoxic and inflammatory re-
sponses induced by MWCNT. We also measured levels
of IL-18 and IL-8 in the supernatants of NLRP3
transfected cells and confirmed that IL-18 production
was indeed inflammasome dependent (Figure 3F) while





Figure 2 MWCNT induce pyroptosis in HBE cells. A) A dose response of MWCNT (1.5-24 μg/mL equivalents 0.37-6.0 μg/cm2) induced cell death
after 24 hours exposure. Cells were analyzed by flow cytometry after labeling with PI. CB (24 μg/mL) and Min-U-Sil (100 μg/mL) were used as negative
and positive particle controls respectively. H2O2 (1 mM) was used as positive control for oxidative stress induced cells death. B) Caspase-1 activation in
HBE cells after 24 hours MWCNT exposure, analyzed by flow cytometry. CB (24 μg/mL) was used as negative control while Min-U-Sil (24 μg/mL) and
LPS (1 μg/mL) were used as positive controls. C) Protection of cell death using specific inhibitors for cathepsin B (CA-074ME, 10 μM) and caspase-1
(Z-WEHD-FMK, 50 μM). Cells were pre-treated (for 1 hour) with these inhibitors before treatment with MWCNT (24 μg/mL) in the presence of inhibitor
for further 24 hours and analyzed by flow cytometry. D) Modulation of cell death by specific siRNA against NLRP3 inflammasome. Transfection of
HBE cells was performed using either specific siRNA against NLRP3 inflammasome or a nonspecific negative control siRNA. Cells were treated with
MWCNT (24 μg/mL) for 24 hours. Cell death was measured by flow cytometry after labeling with PI. Data were analyzed by analysis of variance
(ANOVA) followed by Tukey’s post hoc test. Graphs show average ± SEM of three independent experiments with triplicate of each conditions,
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (between media-treated control and treatments).
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We observed significant dose and time-dependent pro-
duction of ROS after exposure to MWCNT (Figure 4A).
Time dependent phosphorylation of nuclear factor-kappa
B (NF-κB) was also observed after MWCNT exposure
(Figure 4B). NF-κB phosphorylation, loss of mitochondrial
membrane potential (ΔΨm) and lipid peroxidation after
MWCNT exposures were significantly reduced after util-
izing antioxidants (N-acetylCysteine (NAC) and Catalase
poly ethylene glycol (Cat Peg)) (Additional file 8A-C).
Cytotoxic effects of MWCNT were successfully abolished
using NAC or Cat peg (Figure 4C). Moreover, IL-1β pro-
duction was completely inhibited by QNZ (NF- κB inhibi-
tor) in addition to NAC and Cat peg (Figure 4D). It is
noteworthy that ROS and inflammasome activation are
well-established triggers for inflammasome assembly and
cytokine production and all the known triggers of NLRP3
activation are ROS inducers [28].Conditioned medium from MWCNT-treated HBE cells
induce fibroblast proliferation and Pro-fibrotic gene
expression
Pro-fibrotic response was confirmed by evaluating fibro-
blast proliferation by a recently validated in vitro assay and
measuring gene expression for TIMP-1, TN-C, PC1 and
OPN. A conditioned media (CM) approach was developed
to analyze the role of epithelial derived factors in fibroblast
gene expression as co-culturing of epithelial cells and
fibroblasts was not technically possible (Figure 5A). An in-
crease in fibroblast proliferation was observed after expo-
sure to CM from MWCNT treated HBE cells (Figure 5B).
We observed a significant increase in fibroblast gene
expression of TIMP-1, TN-C, PC1 and OPN after CM
exposure for 48 h (Figure 5C). TGF-β, a known inducer of
fibrotic response was used as a positive control. It is note-
worthy that we did not observe an increase in gene expres-




Figure 3 Mechanism of MWCNT induced pro-inflammatory response in HBE cells. A-C) A dose response of cytokine secretion (IL-1β,
IL-18, IL-8) in cell culture supernatants of HBE cells exposed to MWCNT (1.5-24 μg/mL) for 24 hours. LPS (1 μg/mL) was used as positive control.
Quantity of cytokines in cell culture supernatants was estimated using commercially available ELISA/Bioplex kits. D) Modulation of IL-1β
production after pretreatment with pharmacological inhibitors of caspase-1 (Z-WEHD-FMK) and cathepsin B (CA-074Me) or pore blocking agent
(glycine). Cells were pre-treated with these inhibitors as described in Materials and methods and levels of IL-1β in cell culture supernatants were
quantified by commercially available ELISA. E-G) Modulation of IL-1β, IL-18 and IL-8 production by specific siRNA against NLRP3 inflammasome. Data
were analyzed by analysis of variance (ANOVA) followed by Tukey’s post hoc test. Graphs show average ± SEM of three independent experiments with
triplicate of each condition, *p < 0.05, **p < 0.01 and ***p < 0.001, ****p < 0.0001 (between media-treated control and treatment).
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The pro-fibrotic gene expression in fibroblasts de-
pended on NLRP3 inflammasome activation in HBE
Cells, since a significant decrease in the expression of
TIMP-1, TN-C, PC1 and OPN was observed when CM
from HBE cells transfected with NLRP-3 siRNA wasused (Figure 6A-D). Again CM from NLRP3 siRNA
transfected cells did not lead to any change in gene ex-
pression of TGF-β (Figure 6E). The role of IL-1β, IL-18 and
IL-8 was established in the observed responses utilizing
neutralizing antibodies against them (Figure 7A-C). IL-1β









Figure 4 Role of ROS production in MWCNT induced toxicity. A) Dose response of ROS production. HBE cells were treated with different
doses of MWCNT (1.5-24 μg/mL equivalents 0.37-6.0 μg/cm2) for 24 hours. Hydrogen peroxide (1 mM) was used as positive control. ROS were
labeled with HE and analyzed by flow cytometry. At least 10,000 cells/events excluding debris were captured. B) Time course analysis of NF-κB
(REL A/P65) phosphorylation in HBE cells after exposure to 24 μg/mL MWCNT for different time points. Cells based ELISA was performed according to
manufacturers recommendations. C) Modulation of MWCNT induced cell death with antioxidants (NAC and CAT Peg). Cells were pre-treated with
5 mM NAC or CAT Peg (1000 I.U) (30 minutes) and then exposed to MWCNT (24 μg/mL) for 24 hours in the presence of antioxidants. Cell death
analysis was performed using flow cytometry. D) Modulation of MWCNT induced IL-1β production with antioxidants (NAC and CAT Peg) and NF-κB
inhibitor (QNZ). Cells were pre-treated with 5 mM NAC, CAT Peg (1000 I.U) (30 minutes) or QNZ (10 nM) and then exposed to MWCNT (24 μg/mL) for
24 hours in the presence of inhibitors. Cytokine production was analyzed by commercially available ELISA. Data were analyzed by analysis of variance
(ANOVA) followed by Tukey’s post hoc test. Graphs show average ± SEM of three independent experiments with triplicate of each condition, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 (between media-treated control and treatment).
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all cytokines appear to contribute in the induction of TN-C
as their neutralization afforded only partial protection.
Discussion
In the present study we mechanistically investigated
MWCNT-induced cell injury and elaborated its role in
the induction of a profibrotic response. We found that
MWCNT induce pyroptosis and inflammasome activation
in primary human bronchial epithelial cells. Furthermore,
we describe a mechanism through which profibrotic gene
expression is induced in fibroblasts in response to inflam-
masome-derived factors from injured bronchial epithelial
cells. An overview of all these mechanisms is presented in
Figure 8. To the best of our knowledge this is first re-
port confirming inflammasome dependent pro-fibrotic re-
sponse after MWCNT exposures to the primary HBE
cells.Some literature reports have discussed inflammasome
activation in LPS stimulated myeloid cells (mostly cell
lines) after nanotube exposures [29,30]. Myeloid cells are
known to produce enormous amounts of cytokines after
endotoxin stimulation, however it has always been diffi-
cult to establish the relevance of the large amounts of
endotoxin used in vitro with realistic in vivo exposures.
Our study differs from above mentioned work in four
important aspects: 1) We used primary human bronchial
epithelial cells; 2) We uncovered the molecular mecha-
nism of pyroptosis in HBE cells; 3) We observed inflam-
masome activation without prior priming with LPS; and
4) We uncovered the biological significance of the in-
flammasome activation after MWCNT exposure as a
trigger for a pro-fibrotic response. Moreover, it is im-
portant to note that we observed the pro-fibrotic re-
sponse without significant induction of TGF-β which
has been shown to be induced after MWCNT exposure
1.BECs treated with 
MWCNTS (24h)
2.Remove conditioned 
medium and centrifuge to 
remove particles
3.Add 1:4 diluted 
conditioned medium to 
fibroblasts (48 h)
4. Collection of supernatants 




Figure 5 HBE cells conditioned medium induces fibroblast proliferation and profibrotic gene expression. A) Experimental protocol for
conditioned media experimentation. HBE cells were treated with different doses of MWCNT (12, 24 μg/mL equivalents 3.6 μg/cm2) for 24 hours, cell
culture supernatants were removed, centrifuged and diluted 1:4 with DMEM/F-12 medium (without serum). Fibroblasts were grown till near confluence
and serum starved for 24 hours then exposed to conditioned medium from epithelial cells for 48 hours. mRNA was extracted from these cells to
perform pro-fibrotic gene expression analysis using real time quantitative RT-PCR. B) Fibroblast proliferation assay after CM exposure for 48 hours.
TGF-β (10 ng/mL) was used as a positive control. C) Dose response analysis of TIMP-1, TN-C, PC-1, TGF-β and OPN expression in MRC-5 cells after CM
exposures. Data were analyzed by analysis of variance (ANOVA) followed by Tukey’s post hoc test. Graphs show average ± SEM of three independent
experiments with triplicate of each condition, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (between media-treated control and treatment).
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This indicates a potential limitation of these models to
predict human exposures/responses after MWCNT
exposure.
Growing evidence confirms a significant contribution of
airway epithelium in pulmonary immune responses to in-
haled pollutants/allergens [31,32]. It has been shown that
epithelium-derived factors significantly contribute in the
pathogenesis of a variety of respiratory disorders like
asthma, idiopathic pulmonary fibrosis and chronic ob-
structive pulmonary disease [33,34]. This study further
confirms the significance of primary human epithelial cells
as contributors to the innate immune response, as we ob-
served a significant production of inflammatory mediators
from these cells even after non-cytotoxic MWCNT expo-
sures. An exuberant activation of epithelial cells can lead
to an uncontrolled response and thus could have dele-
terious consequences. We further attempted to activate
epithelial cells with LPS to see if cytotoxic responses in-
crease further. Our data indicate these cells are stimulated
to their maximum and cannot be further stimulated
(Additional file 9A). This confirms that production of lowamount of cytokines is indeed a strategy by the body to
avoid uncontrolled immune response. However, it is worth
mentioning that even the low amounts of inflammatory
mediators produced by epithelial cells have significant bio-
logical impact and can lead to fibroblast proliferation and
pro-fibrotic gene expression. We observed no significant
effect of LPS priming on the release of IL-1β and IL-18
from BECs (Additional file 9B-C). These findings are in
line with recently reported observations from silica ex-
posed bronchial cells [35]. Interestingly, we observed sig-
nificant increase in the production of IL-8 after LPS
priming (Additional file 9C). This on one hand confirms
differential signaling cascades for IL-8 production, and on
the other hand further affirms that no increase in IL-β
was a true biological response and could not be attributed
to LPS.
Pro-fibrotic response is characterized by increased fibro-
blast proliferation and excessive ECM deposition either
due to excessive production or impaired turnover. We
studied expression of important components of airway re-
modeling i.e. TN-C, OPN, PC-1 and TIMP-1. We demon-




Figure 6 Role of NLRP3 inflammasome activation in HBE cells in inducing a pro-fibrotic gene expression in fibroblasts. A-E) Modulation
of TIMP-1, TN-C, PC-1, OPN and TGF-β using conditioned media from HBE cells transfected with siRNA against NLRP-3 inflammasome. Data were
analyzed by analysis of variance (ANOVA) followed by Tukey’s post hoc test. Graphs show average ± SEM of three independent experiments with
triplicate of each conditions, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (between media-treated control and treatment).
Hussain et al. Particle and Fibre Toxicology 2014, 11:28 Page 8 of 16
http://www.particleandfibretoxicology.com/content/11/1/28markers after exposure to conditioned medium from
MWCNT treated HBE cells. Increased levels of OPN,
PC-1 and TIMP-1 are noted in rodent lungs in bleomycin
induced pulmonary fibrosis [36-38]. TN-C is prototypic
family member of Tenascin family of extracellular matrix
glycoproteins. TN-C is highly expressed under patho-
logical conditions such as inflammation, infection, tumori-
genesis and wound healing [39]. Recently, it has been
shown that TN-C deficiency attenuates TGF-β-mediatedfibrosis following rodent lung injury [40]. In patients with
asthmatic inflammation enhanced TN-C expression corre-
lates with grade of bronchial inflammation of mast cells
and eosinophils [41]. TIMPs inhibit the activity of matrix
metalloproteinases and thus play and important role in
maintaining a balance between ECM deposition and deg-
radation. TIMP-1 is an important member of the TIMP
family and has known association with different disease
processes in human airways. Increased TIMP-1 levels
A B
C
Figure 7 Role of inflammatory cytokines in conditioned medium from MWCNT treated HBE cells in inducing pro-fibrotic gene expression.
Conditioned medium from MWCNT-treated epithelial cells (24 hour exposure at 24 μg/mL) was incubated with neutralization antibody against
IL-1β (5 μg/mL), IL-18 (5 μg/mL), or IL-8 (10 μg/mL) at 37°C for 30 minutes before adding to the MRC-5 cells. Gene expression of A) TN-C
B) TIMP-1 and C) OPN after 48 hours of exposure was evaluated by real time quantities RT-PCR. Data were analyzed by analysis of variance
(ANOVA) followed by Tukey’s post hoc test. Graphs show average ± SEM of three independent experiments with triplicate of each conditions,
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (between media-treated control and treatment).
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from subjects with asthma and chronic bronchitis [42]. It
was noted that decreased MMP-9/TIMP-1 ratio lead to an
increase in airway wall thickness causing pro-fibrotic
response through increased matrix deposition [43]. It is
worth mentioning that transcriptomic analysis revealed
TIMP-1 induction in mouse lungs after MWCNT instilla-
tion, however monocultures of mouse lung epithelial cells
did not show an increase in TIMP-1 mRNA [44]. This fur-
ther confirms the need to study cellular interactions to ac-
curately describe the effects of nanomaterials. Our results
of increased mRNA expression of OPN are in line with re-
ports describing its over expression after particle and fibre
exposures and in granulomatous lung diseases [45,46].
OPN is a matricellular protein mediator which is upre-
gulated in patients of idiopathic pulmonary fibrosis [47].
Increased levels of OPN cause fibroblast proliferation, mi-
gration and adhesion [48]. Taken together, these literature
findings when combined with our expression data indicatea plausible mechanism of airway remodeling after expos-
ure to conditioned medium from MWCNT treated HBE
cells.
We also characterized the role of NLRP3 inflammasome
activation in HBE cells as a modulator of the pro-fibrotic
response in fibroblasts. NLRP3 inflammasome activation
has been shown in various mammalian cell types (macro-
phages, dendritic cells, monocytes, epithelial cells, fibro-
blasts, keratinocytes and neurons) in response to diverse
stimuli, including microbes, viral RNA, ATP, uric acid
crystals, environmental particles and fibres [29,49-53].
Among various members of the inflammasome family,
NLRP3 has shown to be particularly responsive to danger-
associated molecular patterns (DAMPS) and fibres and
particles including nanomaterials in addition to detecting
pathogen associated molecular patterns (PAMPS) [50,54].
Previously, it was reported that MWCNT-induced macro-
phage activation promotes pulmonary fibrosis through the




























Figure 8 MWCNT-induced cell death (pyroptosis) mechanisms in primary HBE cells and its contribution in pro-fibrotic gene expression
in fibroblasts. Internalization of MWCNT in HBE cells leads to lysosomal damage, release of cathepsin B, ROS production, NF-κB phosphorylation,
NLRP3 inflammasome activation and their inhibition can successfully abolish MWCNT-induced toxicity. NLRP3 inflammasome derived factors from
HBE cells induce pro-fibrotic (TN-C, TIMP-1, PC-1 and OPN) gene expression in MRC-5 cells.
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cells can initiate a profibrotic response through activation
of the NLRP3 inflammasome. Recently, cristobalite silica
induced inflammasome activation in epithelial cells was
shown to induce fibroblast proliferation [35]. Moreover, it
was demonstrated that NLRP3 and ASC deficient mice
did not develop pulmonary fibrosis after bleomycin ex-
posure whereas wild type mice had increased collagen
deposition the lungs [55]. Taken together the results de-
monstrate that the NLRP3 inflammasome can orchestrate
fibrosis in both sterile and pathogen-driven conditions
[56]. The NLRP3 inflammasome has been implicated in
the pathogenesis of various disorders like asbestosis,
silicosis, gout, Alzheimer’s disease and diabetes, mostly
through the production of IL-1β [49,50,53,57]. We
demonstrate here that IL-1β present in conditioned
medium from epithelial cells plays a significant role in
inducing pro-fibrotic gene expression. Indeed, IL-1β is
known to induce TIMP-1 expression through regulation
of AP-1and/or NF-κB in fibroblasts [58]. Moreover, in-
creased expression of OPN is described after exposure to
inflammatory cytokine such as IL-1β [59]. Interestingly,
we show that IL-1β as well as IL-18 and IL-8 contribute in
the induction of TN-C. It is worth mentioning that condi-
tioned medium from HBE cells did not induce toxicity or
ROS production in fibroblasts, thus ruling out oxidative
stress as an effector mechanism for fibroblast proliferation
or pro-fibrotic gene expression (Additional file 10). Taken
together these results clearly demonstrate that inflamma-
some downstream (IL-1β and IL-18) as well as inflamma-
some independent IL-8 contributes in the pro-fibrotic
response after MWCNT exposure. This gene expression
appear to be mainly derived through IL-1β (neutralization
reduces expression of TIMP-1, OPN and TN-C) whereas
other cytokines (IL-18 and IL-8) appear to have onlyminor role (neutralization only protects partially from
TN-C overexpression).
The NLRP-3 inflammasome is well known platform for
the activation of caspase-1 which is driven by induced
proximity. Indeed, in addition to its role in activation of
IL-1β and IL-18, overt inflammasome activation can also
lead to cell death through caspase-1 (Pyroptosis) [60]. Our
results are in line with recent reports describing caspase-1
activation in HBE cells or myeloid cells (monocytes and
macrophages) after exposure to carbon black nanoparti-
cles, silver nanoparticles, cristobalite silica particles, car-
bon nanotubes and cholesterol crystals [29,30,35,61,62].
Our finding of caspase-1 activation after nanotube expo-
sure without priming with LPS is in line with recent litera-
ture describing caspase-1 activation after silica exposure
in epithelial cells [35]. However, using primary HBE cells,
we have additionally explored the expression of pro-
fibrotic genes and verified the role of different cytokines
using specific neutralizing antibodies in MWCNT induced
pro-fibrotic response. Moreover, we demonstrate that the
pro-fibrotic gene expression occur without de novo TGF-
beta expression. We did not find any increase in caspase
3/7 or RIP 1 levels, thus confirming the cell death mo-
dality as pyroptosis and not apoptosis or necroptosis
(Additional file 11). Moreover, we demonstrate here that
inflammasome activation and resulting IL-1β secretion
occur without priming by TLR ligation. These results are
in agreement with recent findings that silica particles and
particulate matter exposure can lead to inflammasome
activation without LPs priming [35,54]. NLRP3 inflam-
masome activation is sometimes described as multistep
process, requiring TLR priming to increase expression of
pro IL-1beta and IL-18 (through NF-kB phosphorylation)
before actual inflammasome assembly. However, various
other triggers e.g. oxidative stress can also activate NF-kB
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ongoing debate whether NLRP3 inflammasome activation
absolutely require TLR-agonist priming. For instance, it
has been shown that NLRP3 assembly and resulting IL-1β
secretion can occur after exposure to various stimuli
without engaging TLR receptors [63-65]. These studies
propose various alternate pathways to explain inflamma-
some assembly without TLR priming includes activation
through danger associated molecular patterns (DAMPS),
P2X7 receptor, serum amyloid A.
Conclusions and perspectives
In conclusion, the results of present study elucidate the
significance of NLRP3 inflammasome activation in epithe-
lial cells as a key mediator of pro-fibrotic gene expression
in MRC-5 cells. Moreover, these results indicate that
MWCNT-induced bronchial epithelial injury shares com-
mon mechanisms with various well-known respiratory
pathologies, such as asthma, COPD, and idiopathic
pulmonary fibrosis. This further raises the possibility of
modulation of pre-existing disorders by nanotubes expo-
sure in susceptible human populations (already shown to
occur in rodent models). Lastly, this study further con-
firms the significance of primary human epithelial cells as
contributors towards the innate immune response. Fur-
ther studies to elucidate the role of differentiation in cell
injury mechanisms, using ex-vivo differentiated bronchial
epithelial cells at air-liquid interfaces, are currently in pro-
gress in our laboratory. More in depth studies using trans-
lational approaches are needed for further clarifying the
human health impacts of nanotubes exposures.
Materials and methods
Nanomaterials and characterization
Commercially available MWCNT (0.5-40 μm length and
10–30 nm external diameter), prepared by chemical
vapor deposition (CVD) method, were utilized in this
study (Helix Material Solutions, Inc., Richardson, TX).
More details about physical characteristics of the bulk
materials used in this study can be found in supporting
information. Carbon black (CB) NPs of 90 nm diameter
(99.9% pure, spherical shape) were used as chemical
composition negative control and were purchased from
Evonik (formerly Degussa). Crystalline Silica particles
(Min-U-Sil (99.2% pure α-Quartz) were used as particu-
late positive control (US Silica Company, Berkeley, CA).
These materials have been used extensively for in vitro
and in vivo exposures to study the toxicity nanomaterials
and their characteristics have already been described
[18,66,67].
Nanomaterial suspensions
Stock suspensions of nanomaterials were made at 2 mg/mL
concentration in BEGM media containing 0.01 mg/mLDipalmitoylphosphatidylcholine (DPPC) and 0.6 mg/mL
Bovine serum Albumin (BSA), both from Sigma Aldrich.
Studies were conducted to know the impact of these
dispersants on the viability, mitochondrial activity and in-
flammation in HBE cells. These results are presented in
Additional file 12. Our results confirmed no harmful effect
of these additives on the studied parameters at all the
tested doses. This dispersion protocol is already described
to yield maximum suspension stability and mimic more
closely the in vivo lung surfactant fluid [13]. All exposure
suspensions were freshly prepared from this stock solution
after sonication for 12 minutes at 235 W (20 s pulses with
a 5 s pause) using a Mesonix S 4000 cuphorn sonicator
(Qsonica LLC, Newtown, CT, USA). After sonication
nanomaterials were suspended in cell culture medium and
used to expose cells within 5 min after vortexing. Dynamic
light scattering analysis was performed to evaluate size
distribution and zeta potentials of nanomaterial sus-
pensions in cell culture medium using ZetaSizer Nano
(Malvern Instruments, Westborough, MA, USA) as de-
scribed by us previously [68]. Electrophoretic mobility was
converted into zeta potential using the Helmholtz-
Smoluchowski equation.
Cells and culture conditions
HBE cells were purchased from Lonza (Walkersville, MD
USA) under the trade name of Normal Human Bronchial
Epithelial Cells. Cells from 5 individuals were utilized in
the present study and all experiments were performed bet-
ween passage 3–4. These cells were cultivated in BEGM
media (BEBM media supplemented with 5 μg/mL insulin,
0.5 ng/mL hEGF, 0.5 μg/mL hydrocortisone, 0.5 μg/mL
epinephrine, 50 μg/mL gentamycin, 50 μg/mL amphote-
racin B, 10 μg/mL transferrin, 6.5 ng/mL triidotyronin,
0.13 mg/mL bovine pituitary extract (all supplied by
Lonza) and 100 μg/mL penicillin and streptomycin (Sigma
Aldrich). Cells were cultivated on non coated plastic ma-
terial (recommended by the supplier) at a density of
20,000 cells per cm2 and kept in an incubator at 37°C, 5%
CO2, and 95% relative humidity. Cells were exposed to
nanomaterials after 72 hours of culture (nearly 90%
confluence). In the experiments involving pharmacological
inhibitors, cells were pre-treated with fresh media contain-
ing inhibitors for desired period of time and then treated
with NP suspensions in the presence of inhibitors. Fol-
lowing inhibitors were used in different experiments:
z-WEHD-FMK (Caspase-1 inhibitor) (R and D Systems,
Minneapolis MN), CA-074Me (Cathepsin B inhibitor)
(Sigma-Aldrich, St. Louis, MO), Staurosporine (apoptosis
positive control) (Sigma-Aldrich, St. Louis, MO).
For cytokine neutralization assays, cells were incubated
for 30 minutes with neutralizing antibodies (anti IL-1β,
anti IL-8 (both from R and D Systems, Minneapolis
MN) or anti IL-18 (MBL, Japan) before treatment with
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24 hours.
MRC-5 fibroblasts were purchased from American Type
Culture Collection (ATCC) and maintained in DMEM/
F12 medium supplemented with 10% Fetal Calf Serum
and 100 μg/mL penicillin and streptomycin. Recently, it
was demonstrated that these cells respond to nanoparticle
exposures in a similar way as primary human lung fibro-
blasts [69]. Cells were cultured in 12 well plates till con-
fluence and then serum starved for 24 hours. Cells were
exposed to a mixture of 1 part CM (from nanotubes
treated HBE cells) and 4 parts DMEM/F12 medium for
48 hours. At the end of exposure period cells were lysed
to collect mRNA for real time RT-PCR analyses. TGF-β
(10 ng/mL) was used as positive control in for fibrosis ex-
periments. We first attempted co-culturing primary HBE
cells and MRC-5 fibroblast cells. However, this approach
was not successful as either medium required for optimal
growth of one type of cells causes either death or changed
morphology of the other cell type. Our experimentation
indicated that primary HBE cells are very sensitive to
serum and media other than BEGM. We observed that
serum containing DMEM (even as low as 10%) results in
changes in morphology and causes cell death (data not
shown). On the other hand fibroblasts react to the
addition of BEGM with morphological changes, altered
metabolic activity and cell death (data not shown). We
therefore adapted a conditioned medium approach to
overcome this hurdle. It is noteworthy that this is also a
more physiologically relevant approach as epithelial cells
are directly exposed to nanomaterials while fibroblasts are
mostly exposed to epithelial secretions and only come in
contact with nanomaterials in case of damaged/denuded
epithelia. This approach has already been reported else-
where to study the toxicity of silica particles [35]. We
verified that CM did not introduce toxicity and ROS pro-
duction in fibroblasts (Additional file 10).
Transmission electron microscopy
HBE cells were grown in two chamber cell culture slides
till sub-confluence and treated with different concentra-
tions of MWCNT for 24 h. At the end of treatment
period, cells were fixed in 3% glutaraldehyde and pro-
cessed for TEM analysis as described previously [68].
Thin sections (80 nm) were cut, placed on formvar cop-
per grids and stained with uranyl acetate and lead cit-
rate. After staining, the sections were examined on a FEI
Tecnai 110 kV microscope at 80 kV, and digital photo-
micrographs were taken.
Validation of In vitro assays
Moreover, necessary measures (using alternate methods
and controls) were taken to avoid artifacts introduced by
the nanomaterials in spectrophotometric and florescentassays. Cytokine ELISA assays were standardized by using
an approach described previously [70]. Known amounts of
cytokine standards were incubated with different nano-
tubes concentrations to verify possible adsorption of cyto-
kines on nanotubes. Particle only controls were also run
in parallel to verify the impact of particles on absorbance
measurements. Cytotoxicity results were verified using
three independent techniques i.e. LDH assay, trypan blue
exclusion cell counts and flow cytometry using propidium
iodide. We observed significant impact of nanotube con-
centrations higher than 24 μg/mL on absorbance (data
not shown). We used approaches described recently in de-
tail to avoid interferences with flow cytometry assays (PI
and ROS production) [71]. Particles were incubated with
fluorochromes to rule out their binding onto particle sur-
faces. No uptake of PI/HE was observed for any type of
particles used in this study. We observed that flow cyto-
metry was least impacted by the nanotubes and it gave
most statistically reliable readings in terms of highest
number of cell counts per conditions.
Flow cytometry
Cell death was quantified in MWCNT treated cells by
flow cytometery using propidium Iodide (PI) probe
which detects the integrity of cell membrane. Briefly, su-
pernatants were collected at the end of treatment period
and cells were trypsinated using 0.025% trypsin-EDTA
(Invitrogen). The action of trypsin was inhibited using
10% fetal bovine serum (Sigma Aldrich, St. Louis, MO,
USA) and cells were mixed with respective supernatant
samples. Cells were centrifuged for 5 minutes at 400 g
and resuspended in cell culture media containing PI
(2.5 μg/mL final concentration). Analysis was performed
using BD FACSAria II equipment at 488 nm excitation
and 615 nm emission wavelengths. After eliminating cell
debris at least 10000 cells were analyzed to determine
the percentage of PI positive cells.
Caspase-1 assay
Caspase-1 activation in HBE cells was quantified using
FAM-FLICA™ Caspase-1 Assay (FAM-YVAD-FMK) kit
(Immunochemistry Technologies, Bloomington, MN).
Cells were labelled according to manufacturers recommen-
dation and analysis was performed using BD FACSAria II
equipment. After eliminating cell debris at least 10000 cells
were analyzed to determine the percentage of capase-1
positive cells.
Cytokine analysis
The concentrations of IL-1 β, IL-18, IL-8, MCP-1 and
IL-13 released into the culture supernatant after 16, 24 or
48 hours MWCNT exposure were evaluated with either
commercially available human enzyme-linked immuno-
sorbent assay (ELISA) kit (R&D Systems, Minneapolis
Table 1 Primer sequences used in the present study for
qPCR analyses
Gene Primers Sequences (5′→ 3′)
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ding to manufacturers recommendations.
siRNA for NLRP3
Cells were transfected using Lipofectamine 2000 reagent
(Block-iT Transfection Kit, Invitrogen) according to man-
ufacturer’s recommendation and incubated with specific
100 nM siRNAs for 24 hours prior to nanomaterial expo-
sures. Silencer select® siRNA against NLRP3 (sense 5′- > 3′
GCUUUGUCCUCGGUACUCAtt and UGAGUACCGAG
GACAAAGCtg, Silencer select® negative control #2 siRNA
(product number 4390846 Ambion®) and BLOCK-iT™
Green Fluorescent Oligo for Lipid Transfection (transfec-
tion control, Invitrogen) were used. Inflammasome down
regulation was verified with RT- qPCR and NLRP3 protein
analyses (Additional file 13).
ROS production
ROS production was estimated by flow cytometery after
staining with Hydroethidine (HE) probe as described by
us previously [72]. After eliminating cell debris at least
10000 cells were analyzed to determine the percentage
of HE positive cells. The graphic presentation of re-
sults was created using FlowJo Software (TreeStar Inc,
Ashland, OR).
Phospho REL A/p65 NF-κB ELISA
Cell based human Phospho-Rel A/p65 (S536) immuno-
assay was performed according to manufacturers recom-
mendations (R and D Systems Minneapolis MN). Assay
results were validated using immunohistochemistry for
phospho p65 (data not shown) and by analyzing neces-
sary controls as mentioned in cytokine estimation assay.
Fibroblast proliferation assay
Fibroblast proliferation was assessed 24 hours after ex-
posure to MWCNT by a recently validated in vitro assay
described in detail elsewhere [73]. We used 10 ng/mL
TGF-β as a positive control.
Real time RT-PCR
Total RNA was collected from adherent cell cultures
using RNEasy Midi Kit (Qiagen, Germantown, MD) ac-
cording to manufacturer’s recommendations. Amount of
RNA was quantified using NanoDrop (Thermo Fisher
Scientific, USA). Reverse transcription (RT) reaction to
obtain cDNA was performed with SuperScript III kit
and oligo dTs (Invitrogen) exactly following manufac-
turer’s recommendations. Final PCR reaction volume
was 25 μL containing Power SYBR Green Master Mix
(Applied Biosciences), 1 μg of cDNA and 500 nM of
each specific forward and reverse primer (Table 1). Data
was collected on a Stratagene Mx3005P real-time PCR
instrument (Agilent, CA, USA). Changes in expressionof target genes were determined by ddCt analysis,
comparing expression to Ribosomal Protein (18 s) and
normalizing to media control. Each fold expression rep-
resents an average of at least 3–5 biological replicates
per treatment group. Following primers were used for
different genes.
Immunocytochemistry (ICH)
ICH analysis was performed to evaluate Cathepsin B
release and phosphorylation and nuclear translocation of
RELA/P65 subunit of NF-κB. Detailed method for the
labelling has been published [72]. Following primary
antibodies were employed: phosphor-NF-κB p65 (Ser536)
(93H1) rabbit monoclonal antibody (Cell Signalling)
(1:100), anti-cathepsin B (CB59-4B11,Sigma-Aldrich)
(1:100). In case of non-conjugated primary antibodies,
Alexa Fluor 488® (1:500) was used as secondary anti-
body and nuclei were counterstained with Hoechst
33342 stain (1 μg/mL). Images were captured using a
Zeiss-Axiovert 40 CFL microscope and processed using
Image J software (NIH, USA).
Western blot analysis
Caspase-1 and RIP-1 levels (total and cleaved) in
MWCNT treated cells were evaluated 24 hours post ex-
posure by immune blots. Briefly, proteins were collected
from scrapped HBE cells using a mixture of RIPA buffer
(Thermo Scientific) and protease inhibitor cocktail (Sigma
Aldrich). Proteins were quantified using micro BCA
(bicinchoninic acid) assay (Thermo Scientific), separated
electrophoretically on a 4-12% bis-tris polyacrylamide
gel and transferred to polyvinylidene difluoride (PVDF)
membrane. Membranes were blocked using 3% BSA and
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clonal antibodies (RIP#3493 and casapse-1#2225, Cell
Signalling) overnight at 4°C. Membrane was extensively
washed after incubation and anti –rabbit HRP-conjugated
secondary antibody (1:10,000) (Cell Signalling) was ap-
plied for 2 hours. After washing, chemiluminescent signal
was developed using ECL Prime (Thermo Scientific) and
detected using GBox digital imaging system (SynGene,
Frederick MD). Densitometric analysis was performed
using Gene-Sys densitometry software (SynGene, Frederick
MD) and signal was normalized to α/β tubulin (#2148, Cell
Signalling) (1:1000).
Mitochondrial membrane potential (ΔΨ)
Mitochondrial membrane potential dynamics were eva-
luated by measuring ΔΨm with mitochondrial selective
probe JC-1 (Invitrogen) according to manufacturer’s re-
commendations. JC-1 is mitochondrial selective probe
which accumulates in the mitochondria in potential de-
pendent manner and show a fluorescence emission shift
from green (~529) to red (~590). Cells with damaged mito-
chondria show higher green fluorescence than red. After
desired incubation periods, cells were stained and live cell
images were taken using Zeiss-Axiovert 40 CFL microscope
and processed using Image J software (NIH, USA).
Lipid peroxidation
Lipid peroxidation was estimated in MWCNT treated cells
using Click-iT® Lipid Peroxidation Imaging Kit - Alexa
Fluor® 488 (Molecular Probes®) according to manufacturers
recommendations. Fluorescence images were taken using
Zeiss-Axiovert 40 CFL microscope and processed using
Image J software (NIH, USA).
Statistical analysis
Data are presented as Mean ± SEM from at least three in-
dependent experiments with triplicate of each condition
during these repeats. Data distribution was analyzed by
D’Agostino-Pearson omnibus normality test. Data were
analyzed using one-way or two-way Analysis of Variance
(ANOVA) followed by Tukey’s post hoc test for multiple
comparisons using Graphpad Prism software Version 6.0
(Graphpad Software Inc. San Diego CA). Differences were
considered statistically significant at p < 0.05 (two-tailed).
Additional files
Additional file 1: Size distribution (DLS Analyses) of nanomaterials
used.
Additional file 2: TEM analysis of MWCNT uptake by HBE cells after
24 hours exposure.
Additional file 3: Kinetics of cytotoxicity in HBE cells after MWCNT
exposure.Additional file 4: LDH Release and Trypan Blue Exclusion counts for
toxicity estimation. A) a dose response of LDH release in the cell
culture supernatants after MWCNT exposure for 24 hours. LDH positive
control (1:5000) dilution was incubated with nanotubes (24 μg/ml) for
24 hours and measured to check for interference with LDH in addition to
using particle only controls for absorbance artifact. B) trypan blue
exclusion counts. Data were analyzed by analysis of variance (ANOVA)
followed by Tukey’s post hoc test. Graphs show average ± SEM of three
independent experiments with triplicate of each condition, *p < 0.05,
***p < 0.001, ****p < 0.0001 (between media-treated control and treatments).
Additional file 5: Dose response analysis of caspase-1 (total and
cleaved/active form) in HBE cells after MWCNT exposure for
24 hours. Tubulin was used as loading control.
Additional file 6: Immunocytochemistry for Cathepsin B in HBE cells
after exposure to MWCNT (24 μg/mL) for 24 hours. Nuclei were counter
stained with Hoechst. Images are representative of 3 independent
experiments done in duplicate.
Additional file 7: Time course for inflammatory cytokine
production.
Additional file 8: A) Modulation of NF-κB (p65) phosphorylation,
B) mitochondrial membrane potential changes and C) lipid peroxidation
assessment using antioxidants (NAC and Cat Peg). Data were analyzed
by analysis of variance (ANOVA) followed by Tukey’s post hoc test.
Graphs show average ± SEM of three independent experiments with
triplicate of each condition, ****p < 0.0001(between media-treated
control and treatments). Images are representative of 3 independent
experiments done in duplicate.
Additional file 9: Modulation of cytotoxicity and inflammation
after LPS pre-stimulation of HBE cells. Cells were pre-stimulated
with 1 μg/mL LPS for 2 hours and then treated with MWCNT (12 or
24 μg/mL) for 24 hours. A) cytotoxicity analysis by PI labelling followed
by flow cytometery. B-D) inflammatory cytokine (IL-1β, IL-18, IL-8)
production measured by ELISA. Data were analyzed by analysis of
variance (ANOVA) followed by Tukey’s post hoc test. Graphs show
average ± SEM of three independent experiments with triplicate of each
condition, **p < 0.01, ****p < 0.0001 (between media-treated control
and treatments).
Additional file 10: Effects of MWCNT treated HBE cell conditioned
medium on A) cytotoxicity (PI analysis) and 2) ROS production
(DHE analysis) from fibroblasts using flow cytometry. MRC-5
medium (DMEM/F12) alone was also used in parallel to know the
non-specific effects of conditioned medium. Data were analyzed by
analysis of variance (ANOVA) followed by Tukey’s post hoc test. Graphs
show average ± SEM of three independent experiments with triplicate
of each condition, ****p < 0.0001 (between media-treated control and
treatments).
Additional file 11: Analysis of other modalities (apoptosis and
necroptosis) of cell death. A) A time course analysis for caspase 3/7
activation after MWCNT exposure using flow cytometery. Staurosporine
(10 μM) was used as a positive control. B) Western blot analysis for
necroptosis protein RIP1. Data were analyzed by analysis of variance
(ANOVA) followed by Tukey’s post hoc test. Graphs show average ±
SEM of three independent experiments with triplicate of each
condition, ****p < 0.0001 (between media-treated control and
treatments).
Additional file 12: Effect of media dispersants (BSA/DPPC) on the
A) toxicity B) metabolic activity C) IL-1β production by HBE cells.
Additional file 13: Efficiency of NLRP3 SiRNA knockout A) real time
RT-qPCR analysis B) immunostaining of HBE cells with our without
NLRP3 SiRNA and with isotype control antibody. Graph shows
average ± SEM of three independent experiments with triplicate of each
condition, **p < 0.01 (between control SiRNA and NLRP3 SiRNA, Students
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